Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro.
Four nucleoside analogues, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAU), -5-iodouracil (FIAU), -5-methylcytosine (FMAC) and -5-iodocytosine (FIAC), were studied for their effect on human cytomegalovirus (HCMV) replication in vitro. FMAU, FIAU, FMAC and FIAC showed antiviral activities for four strains of HCMV (Major, Clegg, D550 and Towne) in a plaque reduction assay, with a dose required for 50% inhibition (ED50) in the range of 0.1 to 0.65 microM. At a concentration of 1 microM-FMAU or -FIAC, the synthesis of five virus-specific late polypeptides of molecular weights 150 000, 120 000, 67000, 54000 and 27000 was entirely blocked. Quantification of Towne viral DNA synthesis, using complementary RNA-DNA hybridization with a Towne-specific cRNA probe, demonstrated a complete inhibition of HCMV DNA replication at 1 microM of FMAU or FIAC. After the removal of the inhibitors, however, viral DNA synthesis resumed, and infectious virus reappeared, indicating that the inhibition of HCMV replication by these nucleoside analogues was of a virostatic reversible type.
D000998:Antiviral Agents / Q000494:pharmacology*; D003587:Cytomegalovirus / Q000187:drug effects* / Q000235:genetics; D004279:DNA, Viral / Q000096:biosynthesis; D003841:Deoxycytidine / Q000031:analogs & derivatives; D003857:Deoxyuridine / Q000031:analogs & derivatives; D006801:Humans; D009705:Nucleosides / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D004279:DNA, Viral; D009705:Nucleosides; D014764:Viral Proteins; D003841:Deoxycytidine; D003857:Deoxyuridine